EMA
- Application: EMEA/H/C/006617
- Marketing authorisation holder: Proveca Pharma Limited
- Local brand name: Bopediat
- Indication: Treatment of all conditions requiring diuresis due to mechanical obstruction or venous insufficiency
- Status: approved
🇪🇺 Furosemide Injection in European Union
Furosemide Injection (Furosemide Injection) regulatory status in European Union.
Marketing authorisation
Furosemide Injection in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Furosemide Injection approved in European Union?
Yes. EMA has authorised it.
Who is the marketing authorisation holder for Furosemide Injection in European Union?
Proveca Pharma Limited holds the EU marketing authorisation.